Swiss National Bank Buys 28,520 Shares of Alnylam Pharmaceuticals, Inc. $ALNYMarket Beat·Jul 21 at 04:21 AMALNY+2.44%
Alnylam Pharmaceuticals (NASDAQ:ALNY) Reaches New 52-Week Low - Time to Sell?Market Beat·Jul 17 at 12:41 PMALNY+2.44%
Alnylam Highlights Progress with Neuroscience Programs at AAIC 2026, Showcasing Potential of RNAi in Neurological Disease | ALNY Stock NewsStockTitan·Jul 14 at 06:30 PMALNY+2.44%
Bank of America Cuts Alnylam Pharmaceuticals (NASDAQ:ALNY) Price Target to $410.00Market Beat·Jul 14 at 09:18 AMALNY+2.44%
Ionis, AstraZeneca Stumble in ATTR-CM Trial as Rivals Stand to Gainbenzinga_article·Jul 10 at 10:30 AMIONS-1.04%AZN+0.22%
Alnylam Pharmaceuticals (ALNY) Could Be 28% Undervalued Following Rival ATTR Trial FailureSimplywall·Jul 10 at 08:23 AMALNY+2.44%AZN
Alnylam climbs 5% in premarket on competitor trial failureUS Stock Market Update·Jul 10 at 03:21 AMALNY+2.44%
Alnylam Pharmaceuticals slips in regular trading after intraday surge fadesUS Stock Market Update·Jul 9 at 12:14 PMALNY+2.44%
Alnylam Pharmaceuticals Surges 12% During Regular Trading on Competitor Drug Trial FailureUS Stock Market Update·Jul 9 at 09:11 AMALNY+2.44%
Major drugmaker loses $27 billion in market value after failed trialDow Jones·Jul 9 at 04:53 AMAZN+0.22%IONS-1.04%
12 Health Care Stocks Moving In Thursday's Pre-Market Sessionbenzinga_article·Jul 9 at 07:05 AMAPVO-4.10%IONS-1.04%
